




Searching News Database: Demyelinating Polyn
HSMN NewsFeed - 15 Jul 2024
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
HSMN NewsFeed - 8 May 2008
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
Additional items found! 3

Members Archive contains
3 additional stories matching:
Demyelinating Polyn
(Password required)
Demyelinating Polyn
(Password required)